Table 3 Inflammatory profile. The data are expressed as the medians and percentiles 25–75 (SD).
Outcome | Group | T1 | T2 | T3 | p |
---|---|---|---|---|---|
Median (25–75%) | |||||
A. Differential count of cells (%) | |||||
Eosinophils | IG | 0.60 (0.20–3.00) | 0.20 (0.00–0.65) | 0.20 (0.00–0.85)* | 0.034* |
CG | 0.00 (0.00–0.20) | 0.10 (0.00–0.60) | 0.20 (0.00–0.20) | 0.568 | |
Neutrophils | IG | 35.40 (10.72–56.10) | 31.80 (13.55–57.65) | 40.60 (6.60–62.85) | 0.971 |
CG | 17.30 (4.40–65.20) | 26.60 (2.282–54.40) | 14.70 (4.20–47.00) | 0.651 | |
Lymphocytes | IG | 1.20 (0.800–2.90) | 1.40 (0.80–2.05) | 1.60 (0.75–2.90) | 0.320 |
CG | 1.00 (0.668–1.40) | 1.00 (0.40–1.60) | 0.80 (0.60–1.40) | 0.911 | |
Macrophages | IG | 54.80 (36.10–87.02) | 60.20 (40.00–82.45) | 56.40 (35.15–90.55) | 0.986 |
CG | 80.40 (32.60–94.60) | 72.30 (44.80–96.88) | 82.90(49.80–95.20) | 0.525 | |
B. Exhaled nitric oxide (NOEX) (PPB) | |||||
IG | 24.6 (17.3–34.1) | 26.7 (23.0–36.1) | 25.5 (15.4–40.3) | 0.585 | |
CG | 26.2 (17.8–39.2) | 21.0 (17.4–23.0) | 22.5 (17.6–30.8) | 0.194 | |
C. Cytokines—induced sputum supernatant | |||||
IL-4 | IG | 1.371 (1.224–1.594) | 0.970 (0.680–1.124)* | 0.858 (0.501–1.092)* | < 0.001* |
CG | 1.140 (0.568–1.464) | 0.786 (0.671–0.962) | 0.419 (0.300–0.590)*** | 0.001* | |
IL-5 | IG | 2.965 (0.967–3.101) | 2.428 (1.918–3,126) | 1.039 (0.967–1.334) *** | 0.010* |
CG | 1.840 (1.195–3.200) | 3.398 (1.627–4.815) | 0.600 (0.380–0.810)*** | < 0.001* | |
D. EBC cytokines | |||||
IL-4 | IG | 0.928(0.800–1.254) | 0.730(0.456–0.982)* | 0.858(0.450–1.076)* | < 0.001* |
CG | 1.124(0.906–1.376) | 0.691(0.454–1.147) | 0.432(0.388–0,695* | 0.011* | |
IL-5 | IG | 2.529(1.709–2.903) | 1.415(1.306–1.735)* | 0.733(0.535–1.025)* | < 0.001* |
CG | 3.324(1.937–4.380) | 1.223(0.841–1.381) | 0.535(0.433–0.765) )*** | < 0.001* | |
IL-17A | IG | 0.855(0.633–1.054) | 0.832(0.681–1.129) | 0.705(0.268–.0.871)** | 0.028* |
CG | 0.448(0.296–1.181) | 0.761(0.665–1.009) | 0.583 (0.444–0.661) | 0.091 |